Skip to main content

Buy Biocon, target Rs 823

We expect company to grow at a CAGR of around 29 percent over next two years which should also improve better profit margins going ahead.

  

Biocon has reported a growth of 21.2 percent in its consolidated revenues at Rs 1,123 crore in Q1-FY19 as against Rs 927 crore in Q1-FY18.
Profit after tax for the company grew by 47 percent and stood at Rs 119 crore in Q1-FY19 against Rs 81 crore in Q1-FY18.
The top 10 brands in its India portfolio reported a strong double digit growth.
The key developments during the quarter were approval of Fulphila (Pegfilgrastim) Biosimilar co-developed by Biocon and Mylan for launch in US markets.
The company’s sterile Drug Product manufacturing facility in Bengaluru received EIR from US FDA and EUGMP certification
Syngene extended its collaboration with Baxter upto 2024 and strengthens its growing client base amongst others.
Going ahead, we continue to expect company to get benefits of first wave of Biosimilar commercialisation in the next two years which should drive higher revenues along with higher growth in formulation business on back of new launches and deeper penetration.
We expect company to grow at a CAGR of around 29 percent over next two years which should also improve better profit margins going ahead.
MORE WILL UPDATE SOON!!

Comments

Popular posts from this blog

Income Tax Deductions List FY 2018-19 | List of important Income Tax Exemptions for AY 2019-20

Budget 2018-19 & the Finance Bill 2018 have been tabled in Parliament. The  Income Tax Slab rates  have been kept unchanged by the Finance Minister for the Financial Year 2018-19  (Assessment Year 2019-2020) . Tax planning is an important part of a financial plan. Whether you are a salaried individual, a professional or a businessman, you can save taxes to certain extent through proper tax planning. The Indian Income Tax act allows for certain Tax Deductions / Tax Exemptions which can be claimed to save tax. You can subtract tax deductions from your Gross Income and your taxable income gets reduced to that extent. In this post, let us go through the  Income Tax Deductions List FY 2018-19 . I hope you find this list useful and helps in planning your taxes well in advance. Income Tax Deductions List FY 2018-19 / AY 2019-20  (Chapter VI-A deductions list) Section 80c The maximum tax exemption limit under Section 80C has been retained as Rs 1.5...

Accumulate ICICI Bank, target Rs 386

Traders can accumulate the stock in a range of Rs 360-364 for the upside target of Rs 386 levels and a stop loss below Rs 345. For more than six weeks, ICICI Bank has been trading in a broader range of Rs 340-365 and is maintaining well above its short and long-term moving averages. At the current juncture, the stock formed an inverted head and shoulder pattern on the daily interval chart. Additionally, the positive divergences on secondary indicators are pointing toward upward movement in prices. So, traders can accumulate the stock in a range of Rs 360-364 for the upside target of Rs 386 levels and a stop loss below Rs 345.  MORE WILL UPDATE SOON!!

How to Stop Overspending of money?

When I first asked myself about “how to stop overspending”, I did not knew that its answer will not be easy. I had to code a whole new financial planning calculator to find a deeper answer. The main purpose of this article is to provide you this financial planning calculator which may eventually help you to prevent your overspending’s. We all have overspent on our days of enthusiasm, right? But this is particularly worrying for people who are more impulsive in purchases. Everyone has their own typical behaviour when it comes to overspending. Generally speaking, people tend to spend more on the following items: Food. Clothes/accessories. Gadgets. Automobiles Home Purchase. Entertainment. Vacation Etc. The reason because you are reading this article says that, you have realised that you may be overspending. So now, you want to know how to stop overspending? Though there can be a thesis written on causes and remedies of overspending, but I will not bore you ...